Geode Capital Management
UTHR icon

Geode Capital Management’s United Therapeutics UTHR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$344M Sell
1,200,365
-23,628
-2% -$6.78M 0.02% 498
2025
Q1
$377M Buy
1,223,993
+85,701
+8% +$26.4M 0.03% 460
2024
Q4
$401M Buy
1,138,292
+44,277
+4% +$15.6M 0.03% 443
2024
Q3
$391M Buy
1,094,015
+45,566
+4% +$16.3M 0.03% 446
2024
Q2
$334M Buy
1,048,449
+220,178
+27% +$70.1M 0.03% 451
2024
Q1
$190M Buy
828,271
+48,509
+6% +$11.1M 0.02% 616
2023
Q4
$171M Sell
779,762
-50,484
-6% -$11.1M 0.02% 605
2023
Q3
$187M Buy
830,246
+23,865
+3% +$5.38M 0.02% 548
2023
Q2
$178M Buy
806,381
+47,238
+6% +$10.4M 0.02% 560
2023
Q1
$170M Buy
759,143
+98,267
+15% +$22M 0.02% 553
2022
Q4
$184M Buy
660,876
+29,137
+5% +$8.1M 0.03% 518
2022
Q3
$132M Sell
631,739
-5,274
-0.8% -$1.1M 0.02% 594
2022
Q2
$150M Sell
637,013
-5,754
-0.9% -$1.36M 0.02% 558
2022
Q1
$115M Sell
642,767
-118,181
-16% -$21.2M 0.01% 704
2021
Q4
$164M Buy
760,948
+62,882
+9% +$13.6M 0.02% 598
2021
Q3
$129M Sell
698,066
-11,713
-2% -$2.16M 0.02% 670
2021
Q2
$127M Buy
709,779
+45,260
+7% +$8.12M 0.02% 675
2021
Q1
$111M Buy
664,519
+5,620
+0.9% +$940K 0.02% 705
2020
Q4
$100M Buy
658,899
+55,777
+9% +$8.47M 0.02% 692
2020
Q3
$60.9M Sell
603,122
-16,707
-3% -$1.69M 0.01% 811
2020
Q2
$75M Buy
619,829
+38,141
+7% +$4.61M 0.02% 677
2020
Q1
$55.2M Buy
581,688
+41,999
+8% +$3.98M 0.01% 721
2019
Q4
$47.5M Buy
539,689
+25,241
+5% +$2.22M 0.01% 970
2019
Q3
$41M Sell
514,448
-2,870
-0.6% -$229K 0.01% 993
2019
Q2
$40.4M Sell
517,318
-56,290
-10% -$4.39M 0.01% 1003
2019
Q1
$67.3M Sell
573,608
-22,007
-4% -$2.58M 0.02% 702
2018
Q4
$64.8M Buy
595,615
+10,863
+2% +$1.18M 0.02% 623
2018
Q3
$74.7M Sell
584,752
-2,435
-0.4% -$311K 0.02% 618
2018
Q2
$66.4M Sell
587,187
-27,475
-4% -$3.11M 0.02% 639
2018
Q1
$69M Sell
614,662
-70,697
-10% -$7.94M 0.02% 608
2017
Q4
$101M Sell
685,359
-61,965
-8% -$9.16M 0.03% 480
2017
Q3
$87.6M Buy
747,324
+47,409
+7% +$5.55M 0.03% 497
2017
Q2
$90.8M Buy
699,915
+40,209
+6% +$5.22M 0.04% 471
2017
Q1
$89.3M Buy
659,706
+66,912
+11% +$9.06M 0.04% 463
2016
Q4
$85M Buy
592,794
+36,623
+7% +$5.25M 0.04% 428
2016
Q3
$65.7M Buy
556,171
+29,543
+6% +$3.49M 0.03% 490
2016
Q2
$55.8M Buy
526,628
+70,909
+16% +$7.51M 0.03% 509
2016
Q1
$50.8K Buy
455,719
+79,502
+21% +$8.86K 0.03% 526
2015
Q4
$58.9M Buy
376,217
+51,922
+16% +$8.13M 0.03% 475
2015
Q3
$42.5M Sell
324,295
-29,691
-8% -$3.89M 0.03% 551
2015
Q2
$61.5M Buy
353,986
+5,583
+2% +$971K 0.04% 470
2015
Q1
$60.1M Buy
348,403
+20,178
+6% +$3.48M 0.03% 468
2014
Q4
$42.5M Buy
328,225
+12,210
+4% +$1.58M 0.03% 543
2014
Q3
$40.7M Buy
316,015
+17,048
+6% +$2.19M 0.03% 533
2014
Q2
$26.5M Buy
298,967
+18,536
+7% +$1.64M 0.02% 704
2014
Q1
$26.4M Buy
280,431
+1,673
+0.6% +$157K 0.02% 693
2013
Q4
$31.5M Buy
278,758
+8,818
+3% +$997K 0.02% 589
2013
Q3
$21.3M Buy
269,940
+5,967
+2% +$471K 0.02% 671
2013
Q2
$17.4M Buy
+263,973
New +$17.4M 0.02% 685